DEA to clamp down on fetanyl production
DEA plans to make N-phenethyl-4-piperidone (NPP) a List I chemical in an effort to control the illicit manufacture of fentanyl, a schedule II controlled substance.
DEA plans to make N-phenethyl-4-piperidone (NPP) a List I chemical in an effort to control the illicit manufacture of fentanyl, a schedule II controlled substance. According to the White House Office of National Drug Control Policy (ONDCP), fentanyl, a synthetic opiate, is 30 to 50 times more powerful than heroin. Heroin and cocaine are often laced with fentanyl. More than 200 deaths in Detroit during 2005 and 2006 were attributed to fentanyl. The proposed DEA rule would subject all handlers of NPP in any quantity to the chemical regulatory provisions of the Controlled Substances Act. Any chemical mixtures containing NPP would also be subject to the regulation. DEA will accept comments on the proposed rule until June 22.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
